Skip to content
★ Sign in to follow
AE

Andrew E. Singer

CFO
Epizyme, Inc.
Total declarations
56
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (18 ops.)
€283k

Latest filing published 10 Aug 2017 for Epizyme, Inc..

Filing timeline

BuySale
Andrew E. Singer

Insider track record

Disclosed buys
0
Disclosed sells
18
Signal history

No signal scores available.

Andrew E. Singer: trading record in brief

Andrew E. Singer is a declared insider of Epizyme, Inc., with filings sourced from SEC (Form 4). Between 9 February 2016 and 9 August 2017, the trades on record add up to 56 filings.

Every open-market trade on record is a sale: 18 sales worth €283k. The rest of the record consists of 38 option exercises. Since January 2017: no purchases and 3 sales on the market.

The newest entry dates from 10 August 2017: an option exercise, in Epizyme, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Andrew E. Singer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations54 total

25 of 54 declarations